75/100
overall score
Total issues found:
24047Updated on: January 7, 2025
Data we analyse
Phishing and malware
23714
issues
Network security
24
issues
Email security
3
issues
Website security
306
issues
Recent critical risk issues we found
38 corporate credentials stolen
300 SSL configuration issues found
4 critical vulnerabilities found
6 high-risk vulnerabilities detected
What information we check
Software patching
Web application security
Email security
Dark web exposure
Cybersecurity Benchmark
A comparison of this company’s cybersecurity ranking with industry averages and peer organizations
Phishing and malware
22
vs.
44
Network security
97
vs.
95
Email security
97
vs.
54
Website security
66
vs.
69
Get Your Free Report
Need help in fixing issues? Contact us and we will help you prepare an action plan to improve your risk rating.
Company overview
Vertex Pharmaceuticals (vrtx.com) is a global biotechnology company headquartered in Boston that discovers, develops and commercializes transformative therapies for serious diseases. Best known for pioneering treatments for cystic fibrosis, Vertex is expanding its pipeline into other genetic and rare diseases using precision medicines and strategic R&D partnerships to advance novel small-molecule and genetic therapies worldwide.
Details
Website:
Industries:
Healthcare
Company size:
1001-5000 employees
Founded:
1989
Headquarters:
Vertex Pharmaceuticals Inc.; 50 Northern Avenue; Boston, MA 02210, US
Outcome reliability
We analyze billions of signals from publicly available sources to deliver validated insights into how your company is perceived externally by threat actors. These insights help security teams respond more quickly to risks, manage zero-day incidents effectively, and reduce overall exposure.
